Tilray Brands (TLRY) Going Strong Amid Diversification Into Beverages and Spring Products Launch

Tilray Brands, Inc. (NASDAQ:TLRY) is one of the best WallStreetBets stocks to buy according to analysts.

On February 26, Tilray Brands, Inc. (NASDAQ:TLRY) reported that Good Supply, one of the company’s prominent cannabis brands, had launched its spring product lineup. The move is aimed at fulfilling the demand for high-quality flavored products across the company’s product range. The development follows TLRY’s progress in the beer distribution business. On February 18, the firm announced that it had signed an exclusive licensing agreement with the Danish brewer Carlsberg Group. The deal allows Tilray to produce and distribute multiple Carlsberg beer brands across the United States, starting January 1, 2027. Under the agreement, the company will have a multi-year license to market, manufacture, distribute, and sell Carlsberg Elephant, 1664, Carlsberg, and Kronenbourg 1664 Blanc across all sales channels in the United States.

Irwin D. Simon, Chairman and CEO of Tilray Brands, Inc. (NASDAQ:TLRY), said in a press release:

This partnership brings together two highly complementary organizations and underscores the strength of Tilray’s beverage platform.

The deal is set for an initial period of five years. If specific performance targets are achieved, it can automatically renew for an additional five years. The company plans to use its sales and marketing team, brewing facilities, and commercial expertise in the United States to locally produce these beers. The agreement is expected to strengthen Tilray’s position in the U.S. beer market.

Chief Growth Officer of Tilray Beverages, Prinz Pinakatt, commented:

Carlsberg’s portfolio aligns well with Tilray Beverages’ expanding platform… We are excited about the potential to create significant long-term value for both companies.

Tilray Brands, Inc. (NASDAQ:TLRY) operates as a lifestyle consumer products company. The company is engaged in the processing, research, distribution, and cultivation of medical cannabis products. It operates in the Middle East, the United States, Canada, Africa, Europe, and around the world.